K Number
K081630
Date Cleared
2008-07-29

(48 days)

Product Code
Regulation Number
892.2050
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images.

It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.

MammoWorkstation is designed to give easy and economic access to and display of multi-modality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.

MammoWorkstation supports teleradiology and teleconferencing providing access to multi-modality softcopy images and structured reports in multiple locations within and outside the hospital.

Lossy compressed mammographic images must not be used for primary diagnostic interpretation unless approved for use in digital mammography.

Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography.

Device Description

The MammoWorkstation is a medical image review workstation software for diagnostic and screening mammography. It is a software product. The product consists of features that allow the qualified medical professional to review patient medical images and to apply tools to cover the relevant aspects of an efficient review workflow. In addition, the system supports creation of report documents.

AI/ML Overview

The provided text describes the "MammoWorkstation" device and its 510(k) summary. However, it does not contain any information about acceptance criteria, device performance metrics, or a study proving its conformance to such criteria.

The document is a regulatory submission for a medical device (MammoWorkstation) seeking clearance from the FDA. It focuses on demonstrating "substantial equivalence" to previously cleared predicate devices, rather than presenting a performance study with specific acceptance criteria and results.

Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets them, nor can I provide the requested tables and details. All the requested points (1-9) would require a detailed performance study, which is absent in this 510(k) summary.

The document primarily states:

  • The product is a medical imaging software for diagnostic and screening mammography.
  • It provides image review, manipulation, analysis, post-processing, and printing capabilities.
  • It supports teleradiology and teleconferencing.
  • It is developed according to ISO 13485:2003, IEC 62304, and ISO 14971, and complies with ACR/NEMA Digital Imaging Communications in Medicine version 3.0.
  • Its intended use and technological characteristics are substantially equivalent to predicate devices (Cedara I-ReadMammo, Sectra Workstation IDS5/mx.net, GE Healthcare Centricity Radiology RA600).
  • Differences lie in higher specialization for mammograms, structured report capabilities aligned with DICOM breast imaging templates, and user interface/automation features (e.g., automatic hanging protocol).

This type of regulatory submission often relies on a review of software development processes, verification and validation activities (which might include internal testing), and comparison to existing devices, but it typically does not present a detailed clinical or technical performance study with quantifiable acceptance criteria and results as you've requested for AI/CAD devices.

{0}------------------------------------------------

Product 11.1 MammoWorkstation

510(k) Summary

(as required by 21 CFR 807.92)

JUL 29 2008

510(k) Number:
Submitter:Image Diagnost International GmbH
Address:Balanstraße 5781541 MünchenGermany
Contact:Dr. Peter Heinlein
Telephone:++49 (89) 450 3666
Date:April 2007
Device Name:Trade Name:MammoWorkstation
Common Name:Medical imaging software
Classification Name:Picture archiving and communication system
Classification:Class II CFR 892.2050 System, Image Processing, Radiological, LLZ
Predicate Devices:1. Cedara Software Corp.510(k) Number: K040468Device: Cedara I-ReadMammo2. Sectra Imtec AB510(k) Number: K063093Device: Sectra Workstation IDS5/mx.net3. GE Healthcare Integrated IT Solutions510(k) Number: K063628Device: Centricity Radiology RA600

Device Description:

The MammoWorkstation is a medical image review workstation software for diagnostic and screening mammography. It is a software product. The product consists of features that allow the qualified medical professional to review patient medical images and to apply tools to cover the relevant aspects of an efficient review workflow. In addition, the system supports creation of report documents.

Indications for use:

"MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images.

It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.

MammoWorkstation is designed to give easy and economic access to and display of multi-modality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.

{1}------------------------------------------------

510(k) Application

MammoWorkstation supports teleradiology and teleconferencing providing access to multi-modality softcopy images and structured reports in multiple locations within and outside the hospital.

Lossy compressed mammographic images must not be used for primary diagnostic interpretation unless approved for use in digital mammography.

Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography. "

All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality quidelines. All modalities must be certified for soft-copy reading.

(Source: Users Manual, MammoWorkstation Version 3.3.2, section 2.3.1)

Techological Characteristics:

The MammoWorkstation Software will run on Windows 2000 and Windows XP operating system for PCs. Appropriate approved displays for softcopy reading of digital mammography are required for diagnostic reading.

Performance Data:

The subject is developed in an environment according to ISO 13485:2003, IEC 62304, and ISO 14971. Further it complies with ACR/NEMA Digital Imaging Communications in Medicine version 3.0.

Comparison to predicate device:

The intended use and technological characteristics of MammoWorkstation are substantially equivalent to those of the predicate devices.

A difference lies in the higher specialization of the MammoWorkstation for application to reading of mammograms. The capability to create structured report documents is not generic, it follows strictly the DICOM breast imaging report templates. Other differences lie in user interface and the degree of automation. The automatic hanging protocol or automatic scaling & alignment of images make mammography image reviewing more convenient to the user. This specialization does not pose any new issues of safety and effectiveness.

The intended use and technological characteristics of MammoWorkstation are substantially equivalent, in the opinion of Image Diagnost International GmbH to those of the predicate devices and to not pose any new issues of safety and effectiveness.

Conclusion:

Similar to the predicate devices, the MammoWorkstation does not contact the patient, nor does it control any life sustaining devices. Images and information being reviewed, processed, relayed, and or transmitted are interpreted by a physician or trained medical personnel, providing ample opportunity for competent hurnan intervention.

Device failures, which might result in partial or failed transmissions, images, or data, may be recovered from storage or re-transmission after correcting the problem(s). Passwords are required for operation and to protect against unauthorized use.

Based on the information supplied in this 510(k), we conclude that the subject device is safe, effective, and substantially equivalent to the predicate devices.

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of a person with their arms outstretched.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL 2 9 2008

Image Diagnost International GmbH % Mr. Stefan Preiss Responsible Third Party Official TÜV SÜD America 1775 Old Hwy 8 NW, Ste 104 NEW BRIGHTON MN 55112-1891

Re: K081630

Trade/Device Name: Mammo Workstation Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: June 8, 2008 Received: June 11, 2008

Dear Mr. Preiss:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.

21 CFR 876.xxxx(Gastroenterology/Renal/Urology)240-276-0115
21 CFR 884.xxxx(Obstetrics/Gynecology)240-276-0115
21 CFR 892.xxxx(Radiology)240-276-0120
Other240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrb/industry/support/index.html.

Sincerely vours.

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Application

Indications for Use

510(k) Number:

Device Name:

MammoWorkstation

Indications For Use:

"MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images.

It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.

MammoWorkstation is designed to give easy and economic access to and display of multi-modality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.

MammoWorkstation supports teleradiology and teleconferencing providing access to multi-modality softcopy images and structured reports in multiple locations within and outside the hospital.

Lossy compressed mammographic images must not be used for primary diagnostic inter- & pretation unless approved for use in digital mammography.

Display monitors used for primary diagnostic interpretation of mammographic images < must be approved for use in digital mammography."

All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines. All modalities must be certified for soft-copy reading.

(Source: Users Manual, MammoWorkstation Version 3.3.2, section 2.3.1)

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) --

Concurrence of CDRH, Office of Device Evaluation (ODE)

Radiological Device "10(k) Number

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).